Huntington National Bank Purchases 255 Shares of Agilent Technologies, Inc. (NYSE:A)

Huntington National Bank increased its holdings in Agilent Technologies, Inc. (NYSE:A) by 9.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,034 shares of the medical research company’s stock after acquiring an additional 255 shares during the period. Huntington National Bank’s holdings in Agilent Technologies were worth $408,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Flynn Zito Capital Management LLC grew its stake in Agilent Technologies by 3.8% during the fourth quarter. Flynn Zito Capital Management LLC now owns 1,871 shares of the medical research company’s stock valued at $251,000 after acquiring an additional 69 shares in the last quarter. IFP Advisors Inc raised its holdings in shares of Agilent Technologies by 17.7% in the 4th quarter. IFP Advisors Inc now owns 458 shares of the medical research company’s stock valued at $62,000 after acquiring an additional 69 shares in the last quarter. Tiemann Investment Advisors LLC grew its holdings in shares of Agilent Technologies by 5.6% during the fourth quarter. Tiemann Investment Advisors LLC now owns 1,423 shares of the medical research company’s stock worth $191,000 after purchasing an additional 75 shares in the last quarter. Rothschild Investment LLC increased its position in shares of Agilent Technologies by 19.2% in the fourth quarter. Rothschild Investment LLC now owns 491 shares of the medical research company’s stock worth $66,000 after purchasing an additional 79 shares during the last quarter. Finally, CIBC Private Wealth Group LLC raised its stake in Agilent Technologies by 1.2% in the fourth quarter. CIBC Private Wealth Group LLC now owns 7,479 shares of the medical research company’s stock valued at $1,025,000 after purchasing an additional 87 shares in the last quarter. 87.42% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the transaction, the chief executive officer now owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Rodney Gonsalves sold 1,908 shares of the business’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $121.98, for a total transaction of $232,737.84. Following the sale, the vice president now owns 21,786 shares in the company, valued at approximately $2,657,456.28. This trade represents a 8.05 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 5,638 shares of company stock worth $731,229 over the last quarter. Corporate insiders own 0.26% of the company’s stock.

Agilent Technologies Trading Down 6.1 %

NYSE:A opened at $102.97 on Friday. The firm has a market capitalization of $29.36 billion, a P/E ratio of 23.67, a P/E/G ratio of 3.26 and a beta of 1.19. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. The company has a fifty day moving average of $130.34 and a 200 day moving average of $135.75. Agilent Technologies, Inc. has a 52 week low of $102.85 and a 52 week high of $155.35.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. The company had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. On average, research analysts predict that Agilent Technologies, Inc. will post 5.57 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a yield of 0.96%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s payout ratio is 22.76%.

Analysts Set New Price Targets

A has been the subject of a number of research reports. Robert W. Baird cut their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research note on Thursday, February 27th. Barclays raised Agilent Technologies from an “underweight” rating to an “equal weight” rating and increased their target price for the company from $135.00 to $145.00 in a research note on Monday, February 10th. Citigroup lifted their price target on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research note on Thursday, December 19th. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Finally, Wells Fargo & Company dropped their target price on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday, December 9th. Seven research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $150.83.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.